Simvastatin is a cholesterol-lowering drug belonging to a class of drugs called "statins". In patients with one or more risk factors for heart disease, Simvastatin can be helpful in preventing cardiovascular disease. Simvastatin was developed by Merck and is now available as a generic drug.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Cholesterol high | 84 |
|
|
|
|
10 | |
| Other | 38 |
|
|
|
3 | ||
| General health | 28 |
|
2 | ||||
| Slow my MS progress | 11 |
|
1 | ||||
| to lower cholesterol | 1 | 0 | |||||
| high cholestrol | 1 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
8 | 40% |
|
|
Doctor's advice
|
5 | 25% |
|
|
Other
|
3 | 15% |
|
|
Personal research
|
2 | 10% |
|
|
Expense
|
1 | 5% |
|
|
Course of treatment ended
|
1 | 5% |
|
|
Not indicated
|
1 | 5% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.